Characterisation of L-Type Amino Acid Transporter 1 (LAT1) Expression in Human Skeletal Muscle by Immunofluorescent Microscopy

被引:32
|
作者
Hodson, Nathan [1 ]
Brown, Thomas [1 ]
Joanisse, Sophie [1 ]
Aguirre, Nick [2 ]
West, Daniel W. D. [3 ]
Moore, Daniel R. [3 ]
Baar, Keith [2 ]
Breen, Leigh [1 ]
Philp, Andrew [1 ]
机构
[1] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Calif Davis, Davis, CA 95616 USA
[3] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5S 1A1, Canada
来源
NUTRIENTS | 2018年 / 10卷 / 01期
基金
英国生物技术与生命科学研究理事会;
关键词
LAT1; leucine; protein; amino acid transport; BLOOD-BRAIN-BARRIER; RESISTANCE EXERCISE; ENDURANCE EXERCISE; PROTEIN-SYNTHESIS; PLASMA-MEMBRANE; GENE-EXPRESSION; IN-VIVO; GROWTH; CELLS; AVAILABILITY;
D O I
10.3390/nu10010023
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The branch chain amino acid leucine is a potent stimulator of protein synthesis in skeletal muscle. Leucine rapidly enters the cell via the L-Type Amino Acid Transporter 1 (LAT1); however, little is known regarding the localisation and distribution of this transporter in human skeletal muscle. Therefore, we applied immunofluorescence staining approaches to visualise LAT1 in wild type (WT) and LAT1 muscle-specific knockout (mKO) mice, in addition to basal human skeletal muscle samples. LAT1 positive staining was visually greater in WT muscles compared to mKO muscle. In human skeletal muscle, positive LAT1 staining was noted close to the sarcolemmal membrane (dystrophin positive staining), with a greater staining intensity for LAT1 observed in the sarcoplasmic regions of type II fibres (those not stained positively for myosin heavy-chain 1, Type II25.07 +/- 5.93, Type I13.71 +/- 1.98, p < 0.01), suggesting a greater abundance of this protein in these fibres. Finally, we observed association with LAT1 and endothelial nitric oxide synthase (eNOS), suggesting LAT1 association close to the microvasculature. This is the first study to visualise the distribution and localisation of LAT1 in human skeletal muscle. As such, this approach provides a validated experimental platform to study the role and regulation of LAT1 in human skeletal muscle in response to various physiological and pathophysiological models.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands
    Huttunen, Johanna
    Agami, Mahmoud
    Tampio, Janne
    Montaser, Ahmed B.
    Huttunen, Kristiina M.
    MOLECULES, 2022, 27 (01):
  • [32] Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET
    Ikotun, Oluwatayo F.
    Marquez, Bernadette V.
    Huang, Chaofeng
    Masuko, Kazue
    Daiji, Miyamoto
    Masuko, Takashi
    McConathy, Jonathan
    Lapi, Suzanne E.
    PLOS ONE, 2013, 8 (10):
  • [33] Anti-tumor effects of mAb against l-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
    Ueda, Shiho
    Hayashi, Hidemi
    Miyamoto, Takako
    Abe, Shinya
    Hirai, Kana
    Matsukura, Kanji
    Yagi, Hideki
    Hara, Yuta
    Yoshida, Kinji
    Okazaki, Shogo
    Tamura, Masakazu
    Abe, Yuki
    Agatsuma, Toshinori
    Niwa, Shin-ichiro
    Masuko, Kazue
    Masuko, Takashi
    CANCER SCIENCE, 2019, 110 (02): : 674 - 685
  • [34] Evaluation of Amino Acid-Mustard Transport as L-Type Amino Acid Transporter 1 (LAT1)-Mediated Alkylating Agents
    Hosoya, Ken-ichi
    Kyoko, Hirokazu
    Toyooka, Naoki
    Kato, Atsushi
    Orihashi, Masahiro
    Tomi, Masatoshi
    Tachikawa, Masanori
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (11) : 2126 - 2130
  • [35] Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
    Barollo, Susi
    Bertazza, Loris
    Watutantrige-Fernando, Sara
    Censi, Simona
    Cavedon, Elisabetta
    Galuppini, Francesca
    Pennelli, Gianmaria
    Fassina, Ambrogio
    Citton, Marilisa
    Rubin, Beatrice
    Pezzani, Raffaele
    Benna, Clara
    Opocher, Giuseppe
    Iacobone, Maurizio
    Mian, Caterina
    PLOS ONE, 2016, 11 (05):
  • [36] L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells
    Satou, Motoyasu
    Wang, Jason
    Nakano-Tateno, Tae
    Teramachi, Mariko
    Suzuki, Tokiko
    Hayashi, Keitaro
    Lamothe, Shawn
    Hao, Yubin
    Kurata, Harley
    Sugimoto, Hiroyuki
    Chik, Constance
    Tateno, Toru
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2020, 515
  • [37] Structural properties for selective and efficient L-type amino acid transporter 1 (LAT1) mediated cellular uptake
    Karkkainen, Jussi
    Gynther, Mikko
    Kokkola, Tarja
    Petsalo, Aleksanteri
    Auriola, Seppo
    Lahtela-Kakkonen, Maija
    Laine, Krista
    Rautio, Jarkko
    Huttunen, Kristiina M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 544 (01) : 91 - 99
  • [38] Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis
    Chuanmeng Zhang
    Jie Xu
    Shanshan Xue
    Jun Ye
    Molecular Diagnosis & Therapy, 2020, 24 : 523 - 536
  • [39] Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)
    Sihui Chen
    Chunhuan Jin
    Ryuichi Ohgaki
    Minhui Xu
    Hiroki Okanishi
    Yoshikatsu Kanai
    Scientific Reports, 14
  • [40] Metformin enhances anti- tumor effect of L-type amino acid transporter 1 (LAT1) inhibitor
    Ueno, Seiji
    Kimura, Toru
    Yamaga, Takashi
    Kawada, Akihiko
    Ochiai, Toshiaki
    Endou, Hitoshi
    Sakurai, Hiroyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 131 (02) : 110 - 117